The Health Economics & Patient Value (HEPV) initiative focuses on the areas of patient access and value. Building off of successful projects in FDA regulatory science, the HEPV initiative will work to increase predictability within CMS and private payor evidentiary processes. Members are developing collaborative projects with CMS, FDA, and private payors that will:

  • Increase patient access to safe, effective, and innovative medical technologies
  • Increase predictability of the thresholds and pathways to coverage
  • Reduce the cost and risk associated with commercializing new technologies
  • Amplify the patient voice and consider methods to include patient preference data in coverage decisions

Health Economics & Patient Value TEST Programs